Literature DB >> 24158372

En face enhanced depth imaging optical coherence tomography features in adult onset foveomacular vitelliform dystrophy.

Nathalie Puche1, Giuseppe Querques, Rocio Blanco-Garavito, Jennyfer Zerbib, Farah Gherdaoui, Julien Tilleul, Florence Coscas, Agnes Glacet-Bernard, Eric H Souied.   

Abstract

BACKGROUND: Our purpose was to describe the different morphological features in adult onset foveomacular vitelliform dystrophy (AOFVD), using en face enhanced depth imaging (EDI) spectral-domain optical coherence tomography (SD-OCT).
METHODS: Thirty eyes of 22 consecutive patients presenting with diagnosis of AOFVD were enrolled. Diagnosis of AOFVD was concluded based on fundus examination, autofluorescence imaging, fluorescein angiography and SD-OCT. En face OCT imaging was obtained with the Spectralis EDI SD-OCT; 97 inverted sections (nine averaged B-scans per image) were acquired.
RESULTS: On en face OCT, vitelliform lesions appeared as regular concentric rings of different reflectivity. From the periphery to center of the ring, we observed: (1) the hypereflective ring representing the inner segment/ outer segment (IS/OS) junction, which was continuous in 23 out of 30 eyes, and (2) a well-detectable hyporeflective ring between the IS/OS junction and vitelliform material in 20 out of 30 eyes; the innermost composant of the lesion was hypereflective, and it corresponded to vitelliform material. In eight out of 30 eyes, a hyporeflective "croissant"-shaped lesion with inferior concavity in the upper part of the hyperreflective material was present. Hypereflective retinal pigment epithelium (RPE) elevations or bumps were detected in 25 out of 30 eyes. These areas of focal RPE thickening or bumps appeared to be intensely hypereflective on infrared reflectance imaging.
CONCLUSION: En face imaging of the retina helps visualizing the distribution of vitelliform material in AOFVD. The sedimentation of vitelliform lesions is characterized by a upper "croissant"-shaped hypoflectivity. The bumps/thickening of RPE appeared as hypereflective lesions on IR imaging.

Entities:  

Mesh:

Year:  2013        PMID: 24158372     DOI: 10.1007/s00417-013-2493-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Adult-onset foveomacular vitelliform dystrophy: a study by optical coherence tomography.

Authors:  Nathanael Benhamou; Eric H Souied; Ricky Zolf; Florence Coscas; Gabriel Coscas; Gisele Soubrane
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

2.  Adult-onset foveomacular vitelliform dystrophy with OCT 3.

Authors:  Nathanael Benhamou; Audrey Messas-Kaplan; Yuval Cohen; Alain Gaudric; Eric H Souied; Gisele Soubrane; Isaac Avni
Journal:  Am J Ophthalmol       Date:  2004-08       Impact factor: 5.258

Review 3.  [Macular vitelliform degeneration in adults. Retrospective study of a series of 85 patients].

Authors:  A Glacet-Bernard; G Soubrane; G Coscas
Journal:  J Fr Ophtalmol       Date:  1990       Impact factor: 0.818

4.  Natural course of adult-onset foveomacular vitelliform dystrophy: a spectral-domain optical coherence tomography analysis.

Authors:  Giuseppe Querques; Raimondo Forte; Lea Querques; Nathalie Massamba; Eric H Souied
Journal:  Am J Ophthalmol       Date:  2011-06-12       Impact factor: 5.258

5.  Histopathologic features of adult-onset foveomacular pigment epithelial dystrophy.

Authors:  G J Jaffe; H Schatz
Journal:  Arch Ophthalmol       Date:  1988-07

6.  Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis.

Authors:  Isabelle Meunier; Audrey Sénéchal; Claire-Marie Dhaenens; Carl Arndt; Bernard Puech; Sabine Defoort-Dhellemmes; Gaël Manes; Delphine Chazalette; Emilie Mazoir; Béatrice Bocquet; Christian P Hamel
Journal:  Ophthalmology       Date:  2011-01-26       Impact factor: 12.079

7.  Acquired vitelliform detachment in patients with subretinal drusenoid deposits (reticular pseudodrusen).

Authors:  Sandrine A Zweifel; Richard F Spaide; Lawrence A Yannuzzi
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

8.  Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene.

Authors:  U Felbor; H Schilling; B H Weber
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

9.  Correlation of visual function impairment and optical coherence tomography findings in patients with adult-onset foveomacular vitelliform macular dystrophy.

Authors:  Giuseppe Querques; Anna V Bux; Rosa Prato; Cristiana Iaculli; Eric H Souied; Nicola Delle Noci
Journal:  Am J Ophthalmol       Date:  2008-04-24       Impact factor: 5.258

10.  Adult vitelliform macular degeneration: a clinicopathological study.

Authors:  J J Arnold; J P Sarks; M C Killingsworth; E K Kettle; S H Sarks
Journal:  Eye (Lond)       Date:  2003-08       Impact factor: 3.775

View more
  4 in total

1.  The suprachoroidal space: from potential space to a space with potential.

Authors:  Elad Moisseiev; Anat Loewenstein; Glenn Yiu
Journal:  Clin Ophthalmol       Date:  2016-01-25

2.  Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy.

Authors:  Andrew W Francis; Justin Wanek; Jennifer I Lim; Mahnaz Shahidi
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

3.  Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography.

Authors:  Justin Wanek; Norman P Blair; Felix Y Chau; Jennifer I Lim; Yannek I Leiderman; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

4.  Enhanced Visualization of Subtle Outer Retinal Pathology by En Face Optical Coherence Tomography and Correlation with Multi-Modal Imaging.

Authors:  Danuta M Sampson; David Alonso-Caneiro; Avenell L Chew; Tina Lamey; Terri McLaren; John De Roach; Fred K Chen
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.